Yifan Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 3.74% vs -6.01% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 625.00% vs -82.65% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,255.50",
          "val2": "1,210.20",
          "chgp": "3.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "138.50",
          "val2": "88.20",
          "chgp": "57.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.80",
          "val2": "10.70",
          "chgp": "10.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.10",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "95.70",
          "val2": "13.20",
          "chgp": "625.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "110.30%",
          "val2": "1.40%",
          "chgp": "10.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.46% vs 26.93% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 15.42% vs 136.54% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,108.00",
          "val2": "5,131.40",
          "chgp": "-0.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "803.50",
          "val2": "735.50",
          "chgp": "9.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "62.50",
          "val2": "78.90",
          "chgp": "-20.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-27.80",
          "val2": "-67.90",
          "chgp": "59.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "373.50",
          "val2": "323.60",
          "chgp": "15.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.40%",
          "val2": "76.00%",
          "chgp": "1.04%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,255.50

1,210.20

3.74%

Operating Profit (PBDIT) excl Other Income

138.50

88.20

57.03%

Interest

11.80

10.70

10.28%

Exceptional Items

-0.10

0.10

-200.00%

Consolidate Net Profit

95.70

13.20

625.00%

Operating Profit Margin (Excl OI)

110.30%

1.40%

10.89%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 3.74% vs -6.01% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 625.00% vs -82.65% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5,108.00

5,131.40

-0.46%

Operating Profit (PBDIT) excl Other Income

803.50

735.50

9.25%

Interest

62.50

78.90

-20.79%

Exceptional Items

-27.80

-67.90

59.06%

Consolidate Net Profit

373.50

323.60

15.42%

Operating Profit Margin (Excl OI)

86.40%

76.00%

1.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -0.46% vs 26.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 15.42% vs 136.54% in Dec 2024

All Annual Results